Ceramide as a Mediator of Non-Alcoholic Fatty Liver Disease and Associated Atherosclerosis

Takhar Kasumov; Ling Li; Min Li; Kailash Gulshan; John P. Kirwan; Xiuli Liu; Stephen Previs; Belinda Willard; Jonathan D. Smith; Arthur McCullough

doi:10.1371/journal.pone.0126910

Loading metrics

Open Access

Peer-reviewed

Research Article

Ceramide as a Mediator of Non-Alcoholic Fatty Liver Disease and Associated Atherosclerosis

Takhar Kasumov ,

* E-mail: kasumot@ccf.org (TK); MCULLA@ccf.org (AM)

Affiliation Department of Gastroenterology& Hepatology, Cleveland Clinic, Cleveland, OH, United States of America
⨯
Ling Li,

Affiliation Department of Research Core Services, Cleveland Clinic, Cleveland, OH, United States of America
⨯
Min Li,

Affiliation Department of Pathobiology, Cleveland Clinic, Cleveland, OH, United States of America
⨯
Kailash Gulshan,

Affiliation Department of Cellular & Molecular Medicine, Cleveland Clinic, Cleveland, OH, United States of America
⨯
John P. Kirwan,

Affiliation Department of Pathobiology, Cleveland Clinic, Cleveland, OH, United States of America
⨯
Xiuli Liu,

Affiliation Department of Anatomic Pathology, Cleveland Clinic, Cleveland, OH, United States of America
⨯
Stephen Previs,

Current address: Merck, Pharmacokinetics, Pharmacodynamics and Drug Metabolism, 126 E. Lincoln Ave., Rahway, NJ, United States of America

Affiliation Department of Nutrition & Medicine, Case Western Reserve University School of Medicine Cleveland Clinic, Cleveland, OH, United States of America
⨯
Belinda Willard,

Affiliation Department of Research Core Services, Cleveland Clinic, Cleveland, OH, United States of America
⨯
Jonathan D. Smith,

Affiliation Department of Cellular & Molecular Medicine, Cleveland Clinic, Cleveland, OH, United States of America
⨯
Arthur McCullough

* E-mail: kasumot@ccf.org (TK); MCULLA@ccf.org (AM)

Affiliations Department of Gastroenterology& Hepatology, Cleveland Clinic, Cleveland, OH, United States of America, Department of Pathobiology, Cleveland Clinic, Cleveland, OH, United States of America
⨯

Ceramide as a Mediator of Non-Alcoholic Fatty Liver Disease and Associated Atherosclerosis

Takhar Kasumov,
Ling Li,
Min Li,
Kailash Gulshan,
John P. Kirwan,
Xiuli Liu,
Stephen Previs,
Belinda Willard,
Jonathan D. Smith,
Arthur McCullough

Published: May 20, 2015
https://doi.org/10.1371/journal.pone.0126910

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Cholesterol
Is the Subject Area "Cholesterol" applicable to this article?

Thanks for your feedback.
Atherosclerosis
Is the Subject Area "Atherosclerosis" applicable to this article?

Thanks for your feedback.
Diet
Is the Subject Area "Diet" applicable to this article?

Thanks for your feedback.
Fatty acids
Is the Subject Area "Fatty acids" applicable to this article?

Thanks for your feedback.
Insulin
Is the Subject Area "Insulin" applicable to this article?

Thanks for your feedback.
Insulin resistance
Is the Subject Area "Insulin resistance" applicable to this article?

Thanks for your feedback.
Inflammation
Is the Subject Area "Inflammation" applicable to this article?

Thanks for your feedback.
Gastrointestinal tract
Is the Subject Area "Gastrointestinal tract" applicable to this article?

Thanks for your feedback.